Clovis Oncology, Inc.
CLVS
CLVS was delisted on the 20th of December, 2022.
152 hedge funds and large institutions have $2.41B invested in Clovis Oncology, Inc. in 2015 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 53 increasing their positions, 48 reducing their positions, and 23 closing their positions.
48% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 23
30% more capital invested
Capital invested by funds: $1.86B → $2.41B (+$549M)
22% more funds holding in top 10
Funds holding in top 10: 9 → 11 (+2)
10% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 48
6% more funds holding
Funds holding: 143 → 152 (+9)
55% less call options, than puts
Call options by funds: $22.7M | Put options by funds: $50.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$38.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.4M |
| 3 |
O
OrbiMed
New York
|
+$20.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.6M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$15.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$27.7M |
| 2 |
Goldman Sachs
New York
|
-$22.2M |
| 3 |
O
OppenheimerFunds
New York
|
-$19.8M |
| 4 |
VAM
Visium Asset Management
New York
|
-$19.1M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$15.8M |
CLVS Hedge Fund Activity: Q1 2015 in Review
152 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q1 2015, worth a combined $2.41B — up 30% from $1.86B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new CLVS positions and 23 closed out — a net gain of 11 holders — while 53 added to existing stakes and 48 trimmed.
The largest buyer was PFM Health Sciences, adding an estimated $38.2M. The largest seller was Pentwater Capital Management, exiting entirely with an estimated $27.7M sold.
- 152 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q1 2015, up from 143 in Q4 2014.
- Funds reported $2.41B of Clovis Oncology, Inc. stock for Q1 2015, up 30% quarter-over-quarter.
- 34 funds opened new Clovis Oncology, Inc. positions in Q1 2015 and 23 closed out, a net change of +11 holders.
- The largest Clovis Oncology, Inc. buyer in Q1 2015 was PFM Health Sciences, an estimated $38.2M added.
- The largest Clovis Oncology, Inc. seller in Q1 2015 was Pentwater Capital Management, an estimated $27.7M sold.
Based on aggregated 13F filings for Q1 2015.